Siemionow Maria, Papay Frank, Alam Daniel, Bernard Steven, Djohan Risal, Gordon Chad, Hendrickson Mark, Lohman Robert, Eghtesad Bijan, Coffman Kathy, Kodish Eric, Paradis Carmen, Avery Robin, Fung John
Cleveland Clinic, Cleveland, OH 44195, USA.
Lancet. 2009 Jul 18;374(9685):203-9. doi: 10.1016/S0140-6736(09)61155-7. Epub 2009 Jul 14.
Multiple reconstructive procedures are common for the reconstruction of complex facial deformities of skin, soft tissues, bony structures, and functional subunits, such as the nose, lips, and eyelids. However, the results have been unsatisfactory. An innovative approach entailing a single surgical procedure of face allograft transplantation is a viable alternative and gives improved results.
On Dec 9, 2008, a 45-year-old woman with a history of severe midface trauma underwent near-total face transplantation in which 80% of her face was replaced with a tailored composite tissue allograft. We addressed issues of immunosuppressive therapy, psychological and ethical outcomes, and re-integration of the patient into society.
After the operation, the patient did well physically and psychologically, and tolerated immunosuppression without any major complication. Routine biopsy on day 47 after transplantation showed rejection of graft mucosa; however, a single bolus of corticosteroids reversed rejection. During the first 3 weeks after transplantation, the patient accepted her new face; 6 months after surgery, the functional outcome has been excellent. In contrast to her status before transplantation, the patient can now breathe through her nose, smell, taste, speak intelligibly, eat solid foods, and drink from a cup.
We show the feasibility of reconstruction of severely disfigured patients in a single surgical procedure using composite face allotransplantation. Therefore, this should be taken in consideration as an early option for severely disfigured patients.
None.
对于皮肤、软组织、骨结构以及诸如鼻、唇和眼睑等功能亚单位的复杂面部畸形的重建,多种重建手术很常见。然而,结果并不令人满意。一种创新方法是采用面部同种异体移植的单一外科手术,这是一种可行的替代方案,且能取得更好的效果。
2008年12月9日,一名有严重面中部创伤史的45岁女性接受了近乎全脸移植手术,其80%的面部被一块定制的复合组织异体移植所替换。我们解决了免疫抑制治疗、心理和伦理结果以及患者重新融入社会等问题。
术后,患者身体和心理状况良好,耐受免疫抑制且未出现任何重大并发症。移植后第47天的常规活检显示移植黏膜出现排斥反应;然而,单次大剂量使用皮质类固醇逆转了排斥反应。在移植后的前3周内,患者接受了自己的新面孔;术后6个月,功能结果极佳。与移植前的状况相比,患者现在能够通过鼻子呼吸、嗅觉、味觉、清晰地说话、吃固体食物以及用杯子喝水。
我们展示了使用复合面部同种异体移植在单一外科手术中重建严重毁容患者的可行性。因此,对于严重毁容患者,应将此作为早期选择加以考虑。
无。